Search Results 1-10 of 5511 for Telangiectasia
Hereditary hemorrhagic telangiectasia (tuh-lan-jee-uk-TAY-zhuh) is an inherited disorder that causes abnormal connections, called arteriovenous ...
The purpose of this study is to evaluate pomalidomide vs. placebo in patients with hereditary hemorrhagic telangiectasia (HHT) with moderate-to-severe epistaxis ...
Publications. See a list of publications about hereditary hemorrhagic telangiectasia by Mayo Clinic doctors on PubMed, a service of the National Library of ...
Hereditary hemorrhagic telangiectasia · Ultrasound imaging. This technique is sometimes used to determine whether the liver is affected by AVMs . · Hormone- ...
placebo in patients with hereditary hemorrhagic telangiectasia (HHT) with moderate-to-severe epistaxis who require parenteral iron infusions or blood ...
HHT is a condition characterized by blood vessel malformations, called telangiectasia and arteriovenous malformations (AVMs), occurring in the brain, nose, ...
Mayo Clinic is a hereditary hemorrhagic telangiectasia (HHT) Center of Excellence. This means that Mayo Clinic has been designated by Cure HHT as being ...
At Mayo Clinic, a hereditary hemorrhagic telangiectasia (HHT) Center of Excellence, various specialists work together to diagnose and treat people who have ...
The objective of Part A of this study is to assess the pharmacokinetics (PK) of pazopanib in Hereditary Hemorrhagic Telangiectasia (HHT) participants. The ...
Ataxia-telangiectasia. This rare childhood disease causes degeneration in the brain and immune system. This increases the risk of other diseases, including ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.